Oncoscience AG attends the Nimotuzumab Global Scientific Meeting, 7th-10th April 2016 in Varadero/ Cuba

Oncoscience | April 7th, 2016

At this global clinical development meeting, more than 150 researches from over 20 countries discuss the latest results on the clinical development program and experiences of the routine use of the commercial product. The first meeting was initiated in 2005 and now the meeting takes place bi-yearly. Oncoscience AG is looking forward to meeting Nimotuzumab-interested collogues from all over the world.